Tir triggers expression of CXCL1 in enterocytes and neutrophil recruitment during Citrobacter rodentium infection

Infection and Immunity

Volumn 83, Issue 9, 2015, Pages 3342-3354

  Crepin, Valerie F ^a   Habibzay, Maryam ^a   Glegola Madejska, Izabela ^a   Guenot, Marianne ^a   Collins, James W ^a   Frankel, Gad ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BACTERIAL PROTEIN; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; DNA; EPITHELIAL CELL ADHESION MOLECULE; MESSENGER RNA; TIR PROTEIN; UNCLASSIFIED DRUG; ACTIN; BACTERIAL SECRETION SYSTEM; CXCL1 PROTEIN, MOUSE;

ACTIN POLYMERIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BACTERIAL CHROMOSOME; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIUM ADHERENCE; CD4+ T LYMPHOCYTE; CHROMOSOME DELETION; CITROBACTER RODENTIUM; CITROBACTER RODENTIUM INFECTION; COLONY FORMING UNIT; CONTROLLED STUDY; ENTEROBACTERIACEAE INFECTION; FEMALE; GENE DELETION; IMMUNE RESPONSE; IN VIVO STUDY; INTESTINE CELL; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTON TRANSPORT; STOP CODON; 3T3 CELL LINE; ANIMAL; BACTERIAL SECRETION SYSTEM; BIOSYNTHESIS; C57BL MOUSE; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS;

ACTINS; ANIMALS; BACTERIAL PROTEINS; BACTERIAL SECRETION SYSTEMS; CHEMOKINE CXCL1; CITROBACTER RODENTIUM; ENTEROBACTERIACEAE INFECTIONS; ENTEROCYTES; FEMALE; FLOW CYTOMETRY; MICE; MICE, INBRED C57BL; MUTAGENESIS, SITE-DIRECTED; NEUTROPHIL INFILTRATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SWISS 3T3 CELLS;

EID: 84939526829     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00291-15     Document Type: Article

References (65)

1. Chen HD, Frankel G. 2005. Enteropathogenic Escherichia coli: unravelling pathogenesis. FEMS Microbiol Rev 29:83-98. http://dx.doi.org/10.1016/j.femsre.2004.07.002.
2. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, Faruque AS, Zaidi AK, Saha D, Alonso PL, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ochieng JB, Omore R, Oundo JO, Hossain A, Das SK, Ahmed S, Qureshi S, Quadri F, Adegbola RA, Antonio M, Hossain MJ, Akinsola A, Mandomando I, Nhampossa T, Acacio S, Biswas K, O'Reilly CE, Mintz ED, Berkeley LY, Muhsen K, Sommerfelt H, Robins-Browne RM, Levine MM. 2013. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 382:209-222. http://dx.doi.org/10.1016/S0140-6736(13)60844-2.
3. Collins JW, Keeney KM, Crepin VF, Rathinam VA, Fitzgerald KA, Finlay BB, Frankel G. 2014. Citrobacter rodentium: infection, inflammation and the microbiota. Nat Rev Microbiol 12:612-623. http://dx.doi.org/10.1038/nrmicro3315.
4. Mundy R, MacDonald TT, Dougan G, Frankel G, Wiles S. 2005. Citrobacter rodentium of mice and man. Cell Microbiol 7:1697-1706. http://dx.doi.org/10.1111/j.1462-5822.2005.00625.x.
5. Higgins LM, Frankel G, Douce G, Dougan G, MacDonald TT. 1999. Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease. Infect Immun 67:3031-3039.
6. Shiomi H, Masuda A, Nishiumi S, Nishida M, Takagawa T, Shiomi Y, Kutsumi H, Blumberg RS, Azuma T, Yoshida M. 2010. Gamma interferon produced by antigen-specific CD4+ T cells regulates the mucosal immune responses to Citrobacter rodentium infection. Infect Immun 78:2653-2666. http://dx.doi.org/10.1128/IAI.01343-09.
7. Geddes K, Rubino SJ, Magalhaes JG, Streutker C, Le Bourhis L, Cho JH, Robertson SJ, Kim CJ, Kaul R, Philpott DJ, Girardin SE. 2011. Identification of an innate T helper type 17 response to intestinal bacterial pathogens. Nat Med 17:837-844. http://dx.doi.org/10.1038/nm.2391.
8. Cua DJ, Tato CM. 2010. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 10:479-489. http://dx.doi.org/10.1038/nri2800.
9. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ, Ouyang W. 2008. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14:282-289. http://dx.doi.org/10.1038/nm1720.
10. Spehlmann ME, Dann SM, Hruz P, Hanson E, McCole DF, Eckmann L. 2009. CXCR2-dependent mucosal neutrophil influx protects against colitis-associated diarrhea caused by an attaching/effacing lesion-forming bacterial pathogen. J Immunol 183:3332-3343. http://dx.doi.org/10.4049/jimmunol.0900600.
11. Manta C, Heupel E, Radulovic K, Rossini V, Garbi N, Riedel CU, Niess JH. 2013. CX(3)CR1(+) macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium. Mucosal Immunol 6:177-188. http://dx.doi.org/10.1038/mi.2012.61.
12. Knutton S, Lloyd DR, McNeish AS. 1987. Adhesion of enteropathogenic Escherichia coli to human intestinal enterocytes and cultured human intestinal mucosa. Infect Immun 55:69-77.
13. Wong AR, Pearson JS, Bright MD, Munera D, Robinson KS, Lee SF, Frankel G, Hartland EL. 2011. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements. Mol Microbiol 80:1420-1438. http://dx.doi.org/10.1111/j.1365-2958.2011.07661.x.
14. Crepin VF, Girard F, Schuller S, Phillips AD, Mousnier A, Frankel G. 2010. Dissecting the role of the Tir:Nck and Tir:IRTKS/IRSp53 signalling pathways in vivo. Mol Microbiol 75:308-323. http://dx.doi.org/10.1111/j.1365-2958.2009.06938.x.
15. McDaniel TK, Jarvis KG, Donnenberg MS, Kaper JB. 1995. A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc Natl Acad Sci U S A 92:1664-1668. http://dx.doi.org/10.1073/pnas.92.5.1664.
16. Jarvis KG, Girón JA, Jerse AE, McDaniel TK, Donnenberg MS, Kaper JB. 1995. Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching-effacing lesions formation. Proc Natl Acad Sci U S A 92:7996-8000. http://dx.doi.org/10.1073/pnas.92.17.7996.
17. Jerse AE, Yu J, Tall BD, Kaper JB. 1990. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci U S A 87:7839-7843. http://dx.doi.org/10.1073/pnas.87.20.7839.
18. Garmendia J, Frankel G, Crepin VF. 2005. Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation. Infect Immun 73:2573-2585. http://dx.doi.org/10.1128/IAI.73.5.2573-2585.2005.
19. Hartland EL, Batchelor M, Delahay RM, Hale C, Matthews S, Dougan G, Knutton S, Connerton I, Frankel G. 1999. Binding of intimin from enteropathogenic Escherichia coli to Tir and to host cells. Mol Microbiol 32:151-158. http://dx.doi.org/10.1046/j.1365-2958.1999.01338.x.
20. Kenny B. 1999. Phosphorylation of tyrosine 474 of the enteropathogenic Escherichia coli (EPEC) Tir receptor molecule is essential for actin nucleating activity and is preceded by additional host modifications. Mol Microbiol 31:1229-1241. http://dx.doi.org/10.1046/j.1365-2958.1999.01265.x.
21. Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey EA, Finlay BB. 1997. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91:511-520. http://dx.doi.org/10.1016/S0092-8674(00)80437-7.
22. Swimm A, Bommarius B, Li Y, Cheng D, Reeves P, Sherman M, Veach D, Bornmann W, Kalman D. 2004. Enteropathogenic Escherichia coli use redundant tyrosine kinases to form actin pedestals. Mol Biol Cell 15:3520-3529. http://dx.doi.org/10.1091/mbc.E04-02-0093.
23. Swimm A, Bommarius B, Reeves P, Sherman M, Kalman D. 2004. Complex kinase requirements for EPEC pedestal formation. Nat Cell Biol 6:795. (Author reply, 6:795-796.) http://dx.doi.org/10.1038/ncb0904-795a.
24. Caron E, Crepin VF, Simpson N, Knutton S, Garmendia J, Frankel G. 2006. Subversion of actin dynamics by EPEC and EHEC. Curr Opin Microbiol 9:40-45. http://dx.doi.org/10.1016/j.mib.2005.12.008.
25. Campellone KG, Leong JM. 2005. Nck-independent actin assembly is mediated by two phosphorylated tyrosines within enteropathogenic Escherichia coli Tir. Mol Microbiol 56:416-432. http://dx.doi.org/10.1111/j.1365-2958.2005.04558.x.
26. Brady MJ, Campellone KG, Ghildiyal M, Leong JM. 2007. Enterohaemorrhagic and enteropathogenic Escherichia coli Tir proteins trigger a common Nck-independent actin assembly pathway. Cell Microbiol 9:2242-2253. http://dx.doi.org/10.1111/j.1462-5822.2007.00954.x.
27. Vingadassalom D, Kazlauskas A, Skehan B, Cheng HC, Magoun L, Robbins D, Rosen MK, Saksela K, Leong JM. 2009. Insulin receptor tyrosine kinase substrate links the E. coli O157:H7 actin assembly effectors Tir and EspF(U) during pedestal formation. Proc Natl Acad Sci U S A 106:6754-6759. http://dx.doi.org/10.1073/pnas.0809131106.
28. Weiss SM, Ladwein M, Schmidt D, Ehinger J, Lommel S, Stading K, Beutling U, Disanza A, Frank R, Jansch L, Scita G, Gunzer F, Rottner K, Stradal TE. 2009. IRSp53 links the enterohemorrhagic E. coli effectors Tir and EspFU for actin pedestal formation. Cell Host Microbe 5:244-258. http://dx.doi.org/10.1016/j.chom.2009.02.003.
29. Whale AD, Hernandes RT, Ooka T, Beutin L, Schuller S, Garmendia J, Crowther L, Vieira MA, Ogura Y, Krause G, Phillips AD, Gomes TA, Hayashi T, Frankel G. 2007. TccP2-mediated subversion of actin dynamics by EPEC 2-a distinct evolutionary lineage of enteropathogenic Escherichia coli. Microbiology 153:1743-1755. http://dx.doi.org/10.1099/mic.0.2006/004325-0.
30. Deng W, Vallance BA, Li Y, Puente JL, Finlay BB. 2003. Citrobacter rodentium translocated intimin receptor (Tir) is an essential virulence factor needed for actin condensation, intestinal colonization and colonic hyperplasia in mice. Mol Microbiol 48:95-115. http://dx.doi.org/10.1046/j.1365-2958.2003.03429.x.
31. Schuller S, Chong Y, Lewin J, Kenny B, Frankel G, Phillips AD. 2007. Tir phosphorylation and Nck/N-WASP recruitment by enteropathogenic and enterohaemorrhagic Escherichia coli during ex vivo colonization of human intestinal mucosa is different to cell culture models. Cell Microbiol 9:1352-1364. http://dx.doi.org/10.1111/j.1462-5822.2006.00879.x.
32. Ritchie JM, Brady MJ, Riley KN, Ho TD, Campellone KG, Herman IM, Donohue-Rolfe A, Tzipori S, Waldor MK, Leong JM. 2008. EspFU, a type III-translocated effector of actin assembly, fosters epithelial associa-tion and late-stage intestinal colonization by E. coli O157:H7. Cell Microbiol 10:836-847. http://dx.doi.org/10.1111/j.1462-5822.2007.01087.x.
33. Mallick EM, Garber JJ, Vanguri VK, Balasubramanian S, Blood T, Clark S, Vingadassalom D, Louissaint C, McCormick B, Snapper SB, Leong JM. 2014. The ability of an attaching and effacing pathogen to trigger localized actin assembly contributes to virulence by promoting mucosal attachment. Cell Microbiol 16:1405-1424. http://dx.doi.org/10.1111/cmi.12302.
34. Mallick EM, McBee ME, Vanguri VK, Melton-Celsa AR, Schlieper K, Karalius BJ, O'Brien AD, Butterton JR, Leong JM, Schauer DB. 2012. A novel murine infection model for Shiga toxin-producing Escherichia coli. J Clin Invest 122:4012-4024. http://dx.doi.org/10.1172/JCI62746.
35. Mundy R, Petrovska L, Smollett K, Simpson N, Wilson RK, Yu J, Tu X, Rosenshine I, Clare S, Dougan G, Frankel G. 2004. Identification of a novel Citrobacter rodentium type III secreted protein, EspI, and roles of this and other secreted proteins in infection. Infect Immun 72:2288-2302. http://dx.doi.org/10.1128/IAI.72.4.2288-2302.2004.
36. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97:6640-6645. http://dx.doi.org/10.1073/pnas.120163297.
37. Batchelor M, Guignot J, Patel A, Cummings N, Cleary J, Knutton S, Holden DW, Connerton I, Frankel G. 2004. Involvement of the intermediate filament protein cytokeratin-18 in actin pedestal formation during EPEC infection. EMBO Rep 5:104-110. http://dx.doi.org/10.1038/sj.embor.7400038.
38. Girard F, Dziva F, van Diemen P, Phillips AD, Stevens MP, Frankel G. 2007. Adherence of enterohemorrhagic Escherichia coli O157, O26, and O111 strains to bovine intestinal explants ex vivo. Appl Environ Microbiol 73:3084-3090. http://dx.doi.org/10.1128/AEM.02893-06.
39. Wiles S, Dougan G, Frankel G. 2005. Emergence of a 'hyperinfectious' bacterial state after passage of Citrobacter rodentium through the host gastrointestinal tract. Cell Microbiol 7:1163-1172. http://dx.doi.org/10.1111/j.1462-5822.2005.00544.x.
40. Girard F, Frankel G, Phillips AD, Cooley W, Weyer U, Dugdale AH, Woodward MJ, La Ragione RM. 2008. Interaction of enterohemorrhagic Escherichia coli O157:H7 with mouse intestinal mucosa. FEMS Microbiol Lett 283:196-202. http://dx.doi.org/10.1111/j.1574-6968.2008.01166.x.
41. Girard F, Crepin VF, Frankel G. 2009. Modelling of infection by enteropathogenic Escherichia coli strains in lineages 2 and 4 ex vivo and in vivo by using Citrobacter rodentium expressing TccP. Infect Immun 77:1304-1314. http://dx.doi.org/10.1128/IAI.01351-08.
42. Kufer TA, Kremmer E, Adam AC, Philpott DJ, Sansonetti PJ. 2008. The pattern-recognition molecule Nod1 is localized at the plasma membrane at sites of bacterial interaction. Cell Microbiol 10:477-486.
43. Allen-Vercoe E, Toh MC, Waddell B, Ho H, DeVinney R. 2005. A carboxyterminal domain of Tir from enterohemorrhagic Escherichia coli O157:H7 (EHEC O157:H7) required for efficient type III secretion. FEMS Microbiol Lett 243:355-364. http://dx.doi.org/10.1016/j.femsle.2004.12.027.
44. Heath RJ, Leong JM, Visegrady B, Machesky LM, Xavier RJ. 2011. Bacterial and host determinants of MAL activation upon EPEC infection: the roles of Tir, ABRA, and FLRT3. PLoS Pathog 7:e1001332. http://dx.doi.org/10.1371/journal.ppat.1001332.
45. Kolaczkowska E, Kubes P. 2013. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 13:159-175. http://dx.doi.org/10.1038/nri3399.
46. Smith K, Humphreys D, Hume PJ, Koronakis V. 2010. Enteropathogenic Escherichia coli recruits the cellular inositol phosphatase SHIP2 to regulate actin-pedestal formation. Cell Host Microbe 7:13-24. http://dx.doi.org/10.1016/j.chom.2009.12.004.
47. Yan D, Wang X, Luo L, Cao X, Ge B. 2012. Inhibition of TLR signaling by a bacterial protein containing immunoreceptor tyrosine-based inhibitory motifs. Nat Immunol 13:1063-1071. http://dx.doi.org/10.1038/ni.2417.
48. Yan D, Quan H, Wang L, Liu F, Liu H, Chen J, Cao X, Ge B. 2013. Enteropathogenic Escherichia coli Tir recruits cellular SHP-2 through ITIM motifs to suppress host immune response. Cell Signal 25:1887-1894. http://dx.doi.org/10.1016/j.cellsig.2013.05.020.
49. Keestra AM, Winter MG, Auburger JJ, Frassle SP, Xavier MN, Winter SE, Kim A, Poon V, Ravesloot MM, Waldenmaier JFT, Tsolis RM, Eigenheer RA, Baumler AJ. 2013. Manipulation of small Rho GTPases is a pathogen-induced process detected by NOD1. Nature 496:233-237. http://dx.doi.org/10.1038/nature12025.
50. Legrand-Poels S, Kustermans G, Bex F, Kremmer E, Kufer TA, Piette J. 2007. Modulation of Nod2-dependent NF-kappaB signaling by the actin cytoskeleton. J Cell Sci 120:1299-1310. http://dx.doi.org/10.1242/jcs.03424.
51. Kufer TA. 2008. Signal transduction pathways used by NLR-type innate immune receptors. Mol Biosyst 4:380-386. http://dx.doi.org/10.1039/b718948f.
52. Bielig H, Lautz K, Braun PR, Menning M, Machuy N, Brugmann C, Barisic S, Eisler SA, Andree M, Zurek B, Kashkar H, Sansonetti PJ, Hausser A, Meyer TF, Kufer TA. 2014. The cofilin phosphatase slingshot homolog 1 (SSH1) links NOD1 signaling to actin remodeling. PLoS Pathog 10:e1004351. http://dx.doi.org/10.1371/journal.ppat.1004351.
53. Berger CN, Crepin VF, Jepson MA, Arbeloa A, Frankel G. 2009. The mechanisms used by enteropathogenic Escherichia coli to control filopodia dynamics. Cell Microbiol 11:309-322. http://dx.doi.org/10.1111/j.1462-5822.2008.01254.x.
54. Arbeloa A, Garnett J, Lillington J, Bulgin RR, Berger CN, Lea SM, Matthews S, Frankel G. 2010. EspM2 is a RhoA guanine nucleotide exchange factor. Cell Microbiol 12:654-664. http://dx.doi.org/10.1111/j.1462-5822.2009.01423.x.
55. Bulgin R, Arbeloa A, Goulding D, Dougan G, Crepin VF, Raymond B, Frankel G. 2009. The T3SS effector EspT defines a new category of invasive enteropathogenic E. coli (EPEC) which form intracellular actin pedestals. PLoS Pathog 5:e1000683. http://dx.doi.org/10.1371/journal.ppat.1000683.
56. Young JC, Clements A, Lang AE, Garnett JA, Munera D, Arbeloa A, Pearson J, Hartland EL, Matthews SJ, Mousnier A, Barry DJ, Way M, Schlosser A, Aktories K, Frankel G. 2014. The Escherichia coli effector EspJ blocks Src kinase activity via amidation and ADP ribosylation. Nat Commun 5:5887. http://dx.doi.org/10.1038/ncomms6887.
57. Li S, Zhang L, Yao Q, Li L, Dong N, Rong J, Gao W, Ding X, Sun L, Chen X, Chen S, Shao F. 2013. Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains. Nature 501:242-246. http://dx.doi.org/10.1038/nature12436.
58. Pearson JS, Riedmaier P, Marches O, Frankel G, Hartland EL. 2011. A type III effector protease NleC from enteropathogenic Escherichia coli targets NF-kappaB for degradation. Mol Microbiol 80:219-230. http://dx.doi.org/10.1111/j.1365-2958.2011.07568.x.
59. Pearson JS, Giogha C, Ong SY, Kennedy CL, Kelly M, Robinson KS, Lung TW, Mansell A, Riedmaier P, Oates CV, Zaid A, Muhlen S, Crepin VF, Marches O, Ang CS, Williamson NA, O'Reilly LA, Bankovacki A, Nachbur U, Infusini G, Webb AI, Silke J, Strasser A, Frankel G, Hartland EL. 2013. A type III effector antagonizes death receptor signalling during bacterial gut infection. Nature 501:247-251. http://dx.doi.org/10.1038/nature12524.
60. Newton HJ, Pearson JS, Badea L, Kelly M, Lucas M, Holloway G, Wagstaff KM, Dunstone MA, Sloan J, Whisstock JC, Kaper JB, Robins-Browne RM, Jans DA, Frankel G, Phillips AD, Coulson BS, Hartland EL. 2010. The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. PLoS Pathog 6:e1000898. http://dx.doi.org/10.1371/journal.ppat.1000898.
61. Baruch K, Gur-Arie L, Nadler C, Koby S, Yerushalmi G, Ben-Neriah Y, Yogev O, Shaulian E, Guttman C, Zarivach R, Rosenshine I. 2011. Metalloprotease type III effectors that specifically cleave JNK and NF-kappaB. EMBO J 30:221-231. http://dx.doi.org/10.1038/emboj.2010.297.
62. Pallett MA, Berger CN, Pearson JS, Hartland EL, Frankel G. 2014. The type III secretion effector NleF of enteropathogenic Escherichia coli activates NF-kappaB early during infection. Infect Immun 82:4878-4888. http://dx.doi.org/10.1128/IAI.02131-14.
63. Wiles S, Clare S, Harker J, Huett A, Young D, Dougan G, Frankel G. 2004. Organ specificity, colonization and clearance dynamics in vivo following oral challenges with the murine pathogen Citrobacter rodentium. Cell Microbiol 6:963-972. http://dx.doi.org/10.1111/j.1462-5822.2004.00414.x.
64. Galan JE, Ginocchio C, Costeas P. 1992. Molecular and functional characterization of the Salmonella invasion gene invA: homology of InvA to members of a new protein family. J Bacteriol 174:4338-4349.
65. Raymond B, Crepin VF, Collins JW, Frankel G. 2011. The WxxxE effector EspT triggers expression of immune mediators in an Erk/JNK and NF-kappaB-dependent manner. Cell Microbiol 13:1881-1893. http://dx.doi.org/10.1111/j.1462-5822.2011.01666.x.